By Risline F. July 9, 2021 11:35 AM Updated July 9, 2021 12:23 PM
To combat the threat of corona virus strains, Pfizer-Bioentech is preparing to ask the European Pharmaceuticals Agency for approval to inject a third dose vaccine within the second 6 months.
Not two without three? When France There has been improvement in the faceCorona virus is highly contagious, The Threat of variations Risk, again, will change course. Then Variation Alpha, This is a method Variation Delta Enter the European arena. More than 60% contagious English strain, Which Mutant Shows a shadow The fourth wave : This is already the origin of the recurrence of the epidemic in various European countries. It is even on track to become a majority in France.
So to counter this threat, The The vaccine is huge Is at the heart of worries. But it can be reducedVaccine efficacy Is this current against mutants? In a press release issued on Thursday, July 8, 2021, Pfizer-BioendechHe shared his observations in a study examining its effects Third dose It is administered 6 months after the second injection. According to the first data, this booster dose will allow five to ten times more efficacy than the protection provided by the first two injections for the virus and its beta variant (South Africa).
About Variation Delta, Pfizer-Bioendech Confirms his Vaccine Gets good results against this variation The third injection This will also strengthen security. A study is underway to confirm this Hypothesis. Thus both companies will place a requestEuropean Pharmaceuticals CompanyTo approve the administration of the second dose within the second 6 months.